Cell surface marker-based capture of neoantigen-reactive CD8+ T-cell receptors from metastatic tumor digests
Background Cellular immunotherapies using autologous tumor-infiltrating lymphocytes (TIL) can induce durable regression of epithelial cancers in selected patients with treatment-refractory metastatic disease. As the genetic engineering of T cells with tumor-reactive T-cell receptors (TCRs) comes to...
Main Authors: | Steven A Rosenberg, Paul Robbins, Biman Paria, Jared J Gartner, Sri Krishna, Satyajit Ray, Rami Yossef, Victoria Hill, Frank J Lowery, Praveen D Chatani, Neilesh B Parikh, Kyle J Hitscherich, Maria Florentin, Alakesh Bera, Maria Parkhust |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-05-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/11/5/e006264.full |
Similar Items
-
1216 Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancers
by: Steven A Rosenberg, et al.
Published: (2023-11-01) -
921 ADGRG1 cell surface expression enriches for neoantigen-reactive CD4 lymphocytes from human tumors
by: Steven A Rosenberg, et al.
Published: (2023-11-01) -
369 Concurrent neoantigen vaccination enhances the antitumor effect of dysfunctional T cells during cell therapy
by: Steven A Rosenberg, et al.
Published: (2023-11-01) -
366 Neoantigen-specific stimulation of T cells for effective cancer adoptive cell therapies
by: Steven A Rosenberg, et al.
Published: (2023-11-01) -
Identification of Neoantigens in Two Murine Gastric Cancer Cell Lines Leading to the Neoantigen-Based Immunotherapy
by: Koji Nagaoka, et al.
Published: (2021-12-01)